Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980016/S964

Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I

Medtronic Cardiac Rhythm Disease Management · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONP980016/S964

What did the FDA approve?

FDA PMA supplement P980016/S964 is an APPR decision for Medtronic Cardiac Rhythm Disease Management’s Cobalt MRI ICD and Cobalt XT MRI ICD lines, identified in the record by the original PMA number and supplement number. The record says the action was for “device labeling updates” and a “change to nominal settings” for the Intrinsic Antitachycardia Pacing feature in applicable Cobalt devices.

The source does not describe which labeling text changed, which nominal setting changed, or any clinical effect. It also does not state a new indication or a new device system approval; it only identifies a supplement to the original PMA.

FDA approval order statement

approval for device labeling updates and change to nominal settings for Intrinsic Antitachycardia Pacing (iATP) feature in applicable Cobalt devices
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980016/S964
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
APPR
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980016 · Original PMA

    VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS

  2. P980016/S964 received

    Application receipt date recorded by FDA.

  3. P980016/S965 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  4. P980016/S966 · Related supplement

    Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I

  5. P980016/S967 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  6. P980016/S964 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980016

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records